{
    "2021-08-16": [
        [
            {
                "time": "",
                "original_text": "国开证券给予天坛生物推荐评级：新设浆站进展超预期，发展有望进入快车道",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "推荐评级",
                        "新设浆站",
                        "进展超预期",
                        "快车道"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业：关注CXO新秀 重点推荐皓元医药、诺泰生物等",
                "features": {
                    "keywords": [
                        "医药生物",
                        "CXO",
                        "皓元医药",
                        "诺泰生物",
                        "重点推荐"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}